Uptake of Oncology Biosimilars: Managed Care Strategies to Improve Value-Based Care Systems

biosimilars in oncology, cost-effective cancer care, healthcare education, bioequivalence studies, biosimilar adoption, cancer treatment protocols

Biosimilars offer a cost-effective alternative in oncology, expanding access to cancer care, but their utilization is inconsistent due to varying perceptions and knowledge among stakeholders. Increasing the adoption of biosimilars requires improved education and understanding among healthcare pro…

Jul 7^th • 25 mins read

Identification of Barriers Preventing Biosimiliar Oncology Medication Adoption

oncology, cancer, biosimilar, barriers, access, obstacles

Biosimilars are biologic medical products that are almost identical to original biologics but are produced by different companies. They are safe, effective, and can reduce costs for insurers and patients. Despite the benefits, barriers exist for oncologists and cancer centers in prescribing biosi…

Oct 27^th • 30 mins read